2nd International Symposium on Prognostic and Therapeutic Implications of RKIP in Cancer

9–10th May 2019 | Heraklion, Crete, Greece

Programme

The topics of the 2018 symposium will cover all features associated with RKIP expression and will include:

  • Biochemical, molecular and genetic regulations of RKIP expression and suppression
  • Post-translational modifications of RKIP and molecular consequences
  • Molecular signals and cross talks regulated by RKIP
  • Molecular mechanisms that inhibit EMT and metastasis by RKIP
  • Molecular mechanisms that activate apoptotic pathways by RKIP
  • In vivo pre-clinical tumor models examining RKIP anti-tumor activities
  • Diagnostic and prognostic roles mediated by RKIP expression levels
  • Novel agents targeting RKIP overexpression and potential therapeutic implications

Full details of the program will be published here soon

Attendance to all scientific presentations is open to the community at no cost.

There is no registration fee.

Meeting venue
Aquila Atlantis Hotel, Heraklion, Greece

  • university of crete school of medicine
  • David Geffen School of Medicine at UCLA